These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 36717525)
21. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome. Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870 [TBL] [Abstract][Full Text] [Related]
22. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases. Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863 [TBL] [Abstract][Full Text] [Related]
23. Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer. Fields JZ; Gao Z; Gao Z; Lewis M; Maimonis P; Harvey J; Lynch HT; Boman BM J Lab Clin Med; 2004 Jan; 143(1):59-66. PubMed ID: 14749686 [TBL] [Abstract][Full Text] [Related]
24. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. Pearlman R; Frankel WL; Swanson B; Zhao W; Yilmaz A; Miller K; Bacher J; Bigley C; Nelsen L; Goodfellow PJ; Goldberg RM; Paskett E; Shields PG; Freudenheim JL; Stanich PP; Lattimer I; Arnold M; Liyanarachchi S; Kalady M; Heald B; Greenwood C; Paquette I; Prues M; Draper DJ; Lindeman C; Kuebler JP; Reynolds K; Brell JM; Shaper AA; Mahesh S; Buie N; Weeman K; Shine K; Haut M; Edwards J; Bastola S; Wickham K; Khanduja KS; Zacks R; Pritchard CC; Shirts BH; Jacobson A; Allen B; de la Chapelle A; Hampel H; JAMA Oncol; 2017 Apr; 3(4):464-471. PubMed ID: 27978560 [TBL] [Abstract][Full Text] [Related]
25. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB; J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259 [TBL] [Abstract][Full Text] [Related]
27. BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts. Lucas AL; Frado LE; Hwang C; Kumar S; Khanna LG; Levinson EJ; Chabot JA; Chung WK; Frucht H Cancer; 2014 Jul; 120(13):1960-7. PubMed ID: 24737347 [TBL] [Abstract][Full Text] [Related]
28. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families. Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885 [TBL] [Abstract][Full Text] [Related]
29. Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer families. Maurer E; Lehman B; Matthäi E; Denzer U; Figiel J; Jesinghaus M; Slater EP; Stefenelli U; Gress TM; Bartsch DK United European Gastroenterol J; 2024 Nov; 12(9):1211-1221. PubMed ID: 39031472 [TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the PALB2 gene in unselected pancreatic cancer patients in the Czech Republic. Borecka M; Zemankova P; Vocka M; Soucek P; Soukupova J; Kleiblova P; Sevcik J; Kleibl Z; Janatova M Cancer Genet; 2016 May; 209(5):199-204. PubMed ID: 27106063 [TBL] [Abstract][Full Text] [Related]
31. Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated. Harinck F; Kluijt I; van Mil SE; Waisfisz Q; van Os TA; Aalfs CM; Wagner A; Olderode-Berends M; Sijmons RH; Kuipers EJ; Poley JW; Fockens P; Bruno MJ Eur J Hum Genet; 2012 May; 20(5):577-9. PubMed ID: 22166947 [TBL] [Abstract][Full Text] [Related]
32. Familial pancreatic cancer: Concept, management and issues. Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467 [TBL] [Abstract][Full Text] [Related]
34. The Spanish Familial Pancreatic Cancer Registry (PANGENFAM): a decade follow-up of individuals at high-risk for pancreatic cancer. Earl J; Fuentes R; Sanchez MEC; de Paredes AGG; Muñoz M; Sanjuanbenito A; Lobo E; Caminoa A; Rodríguez M; Barreto E; López JV; Ruz-Caracuel I; Durán SL; Olcina JRF; Sánchez BL; Páez SC; Torres A; Blázquez J; Sequeros EV; Carrato A Fam Cancer; 2024 Aug; 23(3):383-392. PubMed ID: 38753287 [TBL] [Abstract][Full Text] [Related]
35. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Norris AL; Roberts NJ; Jones S; Wheelan SJ; Papadopoulos N; Vogelstein B; Kinzler KW; Hruban RH; Klein AP; Eshleman JR Fam Cancer; 2015 Mar; 14(1):95-103. PubMed ID: 25240578 [TBL] [Abstract][Full Text] [Related]
36. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort. Schwartz M; Korenbaum C; Benfoda M; Mary M; Colas C; Coulet F; Parrin M; Jonveaux P; Ingster O; Granier S; De Mestier L; Cros J; Riffault A; Muller M; Levy P; Rebours V; Greenhalf W; Soufir N; Hammel P Clin Genet; 2019 Dec; 96(6):579-584. PubMed ID: 31432501 [TBL] [Abstract][Full Text] [Related]
37. A systematic review of the prevalence of germline pathogenic variants in patients with pancreatic cancer. Astiazaran-Symonds E; Goldstein AM J Gastroenterol; 2021 Aug; 56(8):713-721. PubMed ID: 34255164 [TBL] [Abstract][Full Text] [Related]
38. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer. Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018 [TBL] [Abstract][Full Text] [Related]
39. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Vasen HF; Taal BG; Griffioen G; Nagengast FM; Cats A; Menko FH; Oskam W; Kleibeuker JH; Offerhaus GJ; Khan PM Gut; 1994 Sep; 35(9):1262-6. PubMed ID: 7959234 [TBL] [Abstract][Full Text] [Related]
40. Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting for MLH1 and MSH2 inactivation in familial cases. Colombino M; Cossu A; Arba A; Manca A; Curci A; Avallone A; Comella G; Botti G; Scintu F; Amoruso M; D'Abbicco D; d'Agnessa MR; Spanu A; Tanda F; Palmieri G Ann Oncol; 2003 Oct; 14(10):1530-6. PubMed ID: 14504054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]